TRIO-US (Translational Research in Oncology-US) — Los Angeles, California

TRIO-US (Translational Research in Oncology-US) is a clinical research site located in Los Angeles, California, United States 90024.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

TRIO-US (Translational Research in Oncology-US) has participated in 5 clinical trials with 4 currently active.

Therapeutic areas: Breast Neoplasms, Breast Neoplasm, Neoplasm Metastasis.

Sponsors: Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for TRIO-US (Translational Research in Oncology-US)?

TRIO-US (Translational Research in Oncology-US) has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has TRIO-US (Translational Research in Oncology-US) conducted?

TRIO-US (Translational Research in Oncology-US) has 5 clinical trials on record, with 4 currently active. Their work covers Breast Neoplasms, Breast Neoplasm, Neoplasm Metastasis.

Is TRIO-US (Translational Research in Oncology-US) accredited by Crixeo Health?

TRIO-US (Translational Research in Oncology-US) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about TRIO-US (Translational Research in Oncology-US)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.